PLUVICTO 27 mCi/mL
lutetium Lu 177 vipivotide tetraxetan · INJECTION, SOLUTION · Novartis Pharmaceuticals Corporation
PLUVICTO is a injection, solution containing lutetium lu 177 vipivotide tetraxetan at 27 mCi/mL, taken intravenous. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- PLUVICTO
- Generic Name
- lutetium Lu 177 vipivotide tetraxetan
- NDC Code (Product)
0078-1217- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 27 mCi/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA215833
- Drug Class
- Radioligand Therapeutic Agent [EPC]
- Marketing Start
- 03/23/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is PLUVICTO used for?
PLUVICTO contains lutetium Lu 177 vipivotide tetraxetan. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is PLUVICTO a controlled substance?
PLUVICTO is not classified as a controlled substance by the DEA.
What is the generic name for PLUVICTO?
The generic name for PLUVICTO is lutetium Lu 177 vipivotide tetraxetan. There are no other listed brand versions of lutetium Lu 177 vipivotide tetraxetan.
What is the NDC code for PLUVICTO 27 mCi/mL?
The NDC (National Drug Code) for PLUVICTO 27 mCi/mL is 0078-1217, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)